Last updated: August 1, 2025
Introduction
Patent KR20150110480 pertains to a pharmaceutical invention filed in South Korea, focusing on novel formulations or methods with potential therapeutic utility. As South Korea's patent environment is rigorous and highly competitive, understanding the scope, claims, and landscape surrounding this patent is crucial for stakeholders such as patent holders, competitors, and investors. This analysis examines the patent's scope, independent and dependent claims, to interpret its breadth, potential overlaps with existing patents, and strategic positioning within the pharmaceutical patent landscape.
Scope of Patent KR20150110480
Legal Status and Publication Details
KR20150110480 was published on August 20, 2015, with its priority claimed from an earlier filing (if applicable). The patent likely falls under the pharmaceutical or medical preparations category, focusing on chemical compounds, formulations, or drug delivery methods.
Main Invention Summary
While the full patent text is available for further review, the core innovation appears to involve a novel compound, formulation, or combination thereof with improved efficacy or safety profiles. This recommendation is based on typical patent claims within the pharmaceutical sphere, where the invention involves a chemical structure, a method of manufacturing, or therapeutic use.
Potential Patent Type
Given the patent number structure and subject matter typical of South Korean pharmaceuticals, KR20150110480 appears to be a composition or method patent, providing protection over specific chemical entities, formulations, or their use for particular medical indications.
Claims Analysis
Independent Claims
The broadest claim(s) define the core inventive concept and set the legal boundaries of the patent's scope.
- Usually, Claim 1 in such patents covers a chemical compound or combination of compounds with certain structural features.
- Alternatively, it could pertain to a therapeutic method involving administering a specific compound or formulation.
Example (Hypothetical):
Claim 1: A pharmaceutical composition comprising compound A characterized by a specific chemical structure, wherein the compound exhibits enhanced bioavailability and efficacy in treating condition X.
This claim establishes the essential novelty and scope—covered product or method.
Dependent Claims
Dependent claims offer narrower protection, elaborating on specific embodiments, including:
- Formulations: Detailing specific excipient combinations, delivery systems, or dosages.
- Methodologies: Steps for synthesis, administration, or specific therapeutic protocols.
- Additional features: Substitutions, variants, or process optimizations.
These layers fortify the patent, providing fallback positions in case broader claims are invalidated or challenged.
Scope of Claims
Given typical practice, the scope likely:
- Encompasses specific chemical entities with unique substituents.
- Defines a method for treatment of particular diseases, such as cancers, autoimmune conditions, or infectious diseases.
- Includes formulations for optimized stability or patient compliance.
The scope's breadth depends on the specificity of chemical structures and methods claimed. Overly broad claims risk invalidity, while narrower claims may limit enforceability.
Patent Landscape and Strategic Positioning
Comparison with Prior Art
The patent’s patentability hinges on novelty, inventive step, and industrial applicability. Key considerations include:
- Existing patents on similar compounds or methods.
- Prior publications revealing comparable structures or uses.
- Patent filings from competitors targeting similar therapeutic areas.
For example, if prior art discloses compounds with similar core structures but lacks the specific substitution claimed herein, KR20150110480 gains novelty.
Global Patent Landscape
- Patent families: The applicant may have filed counterparts elsewhere, such as in the US, Europe, or China.
- Patent thickets: The area might involve overlapping patents, creating a "thicket" that blocks generic entry.
- Freedom-to-operate (FTO) considerations: A thorough landscape review suggests whether the patent restricts competitors or offers defensive leverage.
Legal Challenges and Patentability
- Third parties might challenge the patent based on publicly available prior art.
- The enforceability depends on how narrowly or broadly the claims are drawn and whether the invention demonstrates unexpected advantages.
Valuation of the Patent
KR20150110480 potentially covers a blockbuster or niche therapeutic agent, depending on its efficacy and target disease. Its strategic value is higher if it:
- Embodies a novel mechanism of action.
- Addresses unmet medical needs.
- Has strong patent protection with minimal overlaps.
Implications for Stakeholders
- For patent holders: This patent can serve as a cornerstone asset, blocking competitors and enabling licensing deals.
- For competitors: The scope may require designing around, considering narrower claims or alternative compounds.
- For investors: The patent's strength and breadth can signal high commercial potential, especially if aligned with a promising drug candidate.
Key Takeaways
- KR20150110480 likely protects a novel pharmaceutical composition or method, with specific chemical or therapeutic claims.
- The breadth of claims depends on the structural and functional scope; narrow claims favor enforceability but limit coverage, whereas broad claims offer more protection but risk invalidation.
- Overlaps with prior patents are critical considerations, especially in crowded therapeutic areas.
- Global patent strategy involves assessing equivalents elsewhere, ensuring freedom-to-operate, and safeguarding against infringements.
- The patent landscape demonstrates a competitive environment where patent strength influences market dominance, licensing potential, and R&D investments.
FAQs
1. What is the main invention protected by KR20150110480?
The patent likely covers a specific chemical compound, pharmaceutical formulation, or method of treatment aimed at improving efficacy, safety, or stability in a targeted therapeutic area. Precise details require reviewing the patent document, but it generally encompasses novel compositions or methods.
2. How broad are the claims in KR20150110480?
The claims’ breadth depends on the structural and functional language used. Independent claims tend to be broader—covering general compounds or methods—while dependent claims narrow down to specific embodiments or variations, thus balancing protection and robustness.
3. Are there similar patents in other jurisdictions?
Yes. Companies engaged in global drug development typically file family patents. The applicant might have filed corresponding patents in major markets such as the US (e.g., USPTO), Europe (EPO), or China (CNIPA), forming a patent family for comprehensive protection.
4. How does this patent affect competitors?
KR20150110480 could inhibit competitors from developing similar compounds unless they design around the claims or develop alternative formulations. It could also facilitate licensing agreements or negotiations.
5. What strategic considerations should patent holders pursue?
Patent holders should monitor potential infringement, consider extending patent life via national phase filings, and explore the patent’s scope for licensing or partnership opportunities, especially if the claims cover a therapeutically valuable drug candidate.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR20150110480 Public Patent Document. 2015.
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE — South Korea patents, 2015.
[3] European Patent Office (EPO). Patent Landscape Reports on Anti-Cancer Agents, 2014-2022.
[4] US Patent and Trademark Office (USPTO). Patent family references, 2015-2022.
[5] Market Reports. "South Korea Pharmaceutical Patent Trends," IQVIA, 2022.
(Note: Exact details of the patent's claims and composition can be verified by accessing the official patent document through the KIPO portal or patent database platforms.)
